Accelerating Low-Cost Production of Consistent, Safe & Scalable Vectors for Cell & Gene Therapy to Ensure Regulatory Compliance & Clinical Success
With growing cost pressures, increasing regulatory scrutiny, and safety concerns reshaping the viral vector landscape, the field is at a pivotal inflection point. Developers are seizing new opportunities to improve scalability, reduce COGs, and strengthen batch consistency through smarter, data-driven manufacturing.
The Viral Vector Process Development & Manufacturing Summit returned to Boston for its' 4th year as the only industry-led meeting dedicated to advancing process development and CMC for AAV, LV, RV, and emerging vector delivery systems.
Attendees joined peers from the likes of from Sanofi, Ultragenyx, Cabaletta Bio, Kite Pharmaceuticals, UCB, Obsidian Therapeutics to uncover practical solutions in process optimization, automation, and regulatory alignment that are transforming vector manufacturing in 2026.
If you are interested in the 2027 event, please get in touch at info@hansonwade.com.
The organization of the conference was really well done. The interactive sessions - both during the workshops and during the main conference - were a key component that I really enjoyed.
Jorge Santiago-Oritz, Vice President - Chemistry, Manufacturing, Controls & Regulatory Affairs, Apertura Gene Therapy, 2025 Speaker
I’m excited to speak at the 2026 Viral Vector Process Development and Manufacturing Summit -it’s an excellent opportunity to spotlight challenges and innovations shaping the future of gene therapy manufacturing. Engaging with experts across industry and regulation to exchange perspectives is essential for advancing both quality and access in this rapidly evolving field.
Brett Howard, Senior Director, US Regulatory Policy, US Pharmacopeia, 2026 Speaker
Explore The 2026 Full Event Guide
- 16+ expert speakers from the likes of Sanofi, Ultragenyx, NCI, USP, Apertura, and Rocket Pharma
- 2 days of cutting-edge content tackling the toughest challenges in reducing COGs, improving process consistency, and scaling up viral vector production
- 5 Interactive sessions and 2 hours of dedicated networking
- Dedicated sessions on upstream and downstream streamlining
- Global perspectives on regulatory harmonization and pharmacopeial alignment
Official 2026 Partners
Expertise Partners
Innovation Partners
Exhibition Partners
Event Partner
Attending Companies Included
Explore Related Events
Explore the 2026 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us in 2027
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.